However, NFE2L2 (21%) and PTEN (16%) mutations were more frequent in LUSC, whereas NOTCH1 (13%) and CREBBP (11%) alterations were more common in SCLC. This evidence concerns the gene NFE2L2 and small cell lung carcinoma.